Last Price
1.61
Today's Change
+0.03 (1.89%)
Day's Change
1.58 - 1.65
Trading Volume
234,129
Market Cap
105 Million
Shares Outstanding
65 Million
Avg Volume
797,204
Avg Price (50 Days)
1.66
Avg Price (200 Days)
1.82
PE Ratio
-1.34
EPS
-1.20
Earnings Announcement
07-Nov-2024
Previous Close
1.58
Open
1.64
Day's Range
1.585 - 1.65
Year Range
1.08 - 3.79
Trading Volume
234,129
1 Day Change
1.90%
5 Day Change
3.21%
1 Month Change
1.26%
3 Month Change
-35.08%
6 Month Change
-33.74%
Ytd Change
22.90%
1 Year Change
-3.01%
3 Year Change
-78.53%
5 Year Change
-81.06%
10 Year Change
-99.82%
Max Change
-99.68%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
actvtrader
I like the 50.00 price target for yahoo!
2014-10-22 15:48